(firstQuint)Medtronic Terminate AF Study.

 This is a multi-center, single-arm, prospective, non-randomized, interventional study.

 A maximum of 160 subjects will be treated at up to 15 centers in the US.

 The study will include male and female patients with a history of non-paroxysmal atrial fibrillation who are undergoing concomitant cardiac surgery.

 Subjects will be followed and assessed after procedure and for 12 months.

 The purpose of this study is to evaluate the safety and effectiveness of the Cardioblate Surgical Ablation iRF hand held devices to support an indication expansion to include treatment of non-paroxysmal atrial fibrillation to the product labeling.

.

 Medtronic Terminate AF Study@highlight

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF hand held devices for the treatment of non-paroxysmal AF.

